The company has also come up with a patient assistance programme which will allow patients and institutions who have limited resources to purchase the medicine at a highly subsidised rate, BDR Pharmaceuticals said in a statement.from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-bdr-pharmaceuticals-launches-favipiravir-at-rs-63-per-tabletindia_14126401.html
No comments:
Post a Comment